Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial
ConclusionsIn patients with ACS, ticagrelor significantly reduced the incidence of MI compared with clopidogrel, with consistent results across most MI subtypes. CEC procedures identified more MI endpoints compared with site investigators. (A Comparison of Ticagrelor [AZD6140] and Clopidogrel in Patients With Acute Coronary Syndrome [PLATO]; NCT00391872)
Source: Journal of the American College of Cardiology: Cardiovascular Imaging - Category: Radiology Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clopidogrel | Coronary Angioplasty | Coronary Artery Bypass Graft | Heart | Heart Attack | Percutaneous Coronary Intervention | Plavix | Radiology | Statistics | Stroke | Study | Thrombosis